Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
The Royal London Hospital, Barts Health NHS Trust, Whitechapel, London, UK.
Sci Rep. 2022 Jan 10;12(1):386. doi: 10.1038/s41598-021-03563-7.
Disability in Parkinson's disease (PD) is measured by standardised scales including the MDS-UPDRS, which are subject to high inter and intra-rater variability and fail to capture subtle motor impairment. The BRadykinesia Akinesia INcoordination (BRAIN) test is a validated keyboard tapping test, evaluating proximal upper-limb motor impairment. Here, a new Distal Finger Tapping (DFT) test was developed to assess distal upper-limb function. Kinetic parameters of the test include kinesia score (KS20, key taps over 20 s), akinesia time (AT20, mean dwell-time on each key) and incoordination score (IS20, variance of travelling time between key taps). To develop and evaluate a new keyboard-tapping test for objective and remote distal motor function in PD patients. The DFT and BRAIN tests were assessed in 55 PD patients and 65 controls. Test scores were compared between groups and correlated with the MDS-UPDRS-III finger tapping sub-scores. Nine additional PD patients were recruited for monitoring motor fluctuations. All three parameters discriminated effectively between PD patients and controls, with KS20 performing best, yielding 79% sensitivity for 85% specificity; area under the receiver operating characteristic curve (AUC) = 0.90. A combination of DFT and BRAIN tests improved discrimination (AUC = 0.95). Among three parameters, KS20 showed a moderate correlation with the MDS-UPDRS finger-tapping sub-score (Pearson's r = - 0.40, p = 0.002). Further, the DFT test detected subtle changes in motor fluctuation states which were not reflected clearly by the MDS-UPDRS-III finger tapping sub-scores. The DFT test is an online tool for assessing distal movements in PD, with future scope for longitudinal monitoring of motor complications.
帕金森病(PD)中的残疾通过包括 MDS-UPDRS 在内的标准化量表进行测量,这些量表存在较高的组内和组间变异性,且无法捕捉到细微的运动障碍。BRadykinesia Akinesia INcoordination (BRAIN) 测试是一种经过验证的键盘敲击测试,用于评估近端上肢运动障碍。在这里,开发了一种新的远端手指敲击(DFT)测试来评估远端上肢功能。该测试的运动学参数包括运动得分(KS20,20 秒内敲击的键数)、无运动时间(AT20,每个键的平均停留时间)和不协调得分(IS20,敲击键之间的行进时间方差)。开发并评估一种新的键盘敲击测试,用于客观和远程评估 PD 患者的远端上肢运动功能。在 55 名 PD 患者和 65 名对照组中评估了 DFT 和 BRAIN 测试。比较了两组之间的测试分数,并与 MDS-UPDRS-III 手指敲击子评分相关联。另外招募了 9 名 PD 患者来监测运动波动。所有三个参数都能有效地将 PD 患者与对照组区分开来,KS20 表现最佳,灵敏度为 79%,特异性为 85%;受试者工作特征曲线(ROC)下面积(AUC)为 0.90。DFT 和 BRAIN 测试的组合提高了区分度(AUC=0.95)。三个参数中,KS20 与 MDS-UPDRS 手指敲击子评分呈中度相关(Pearson r=-0.40,p=0.002)。此外,DFT 测试检测到运动波动状态的细微变化,而这些变化在 MDS-UPDRS-III 手指敲击子评分中没有明显反映出来。DFT 测试是一种评估 PD 中远端运动的在线工具,具有对运动并发症进行纵向监测的未来潜力。